We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Taste-Based Influenza Test Could Replace Nasal Swabs with Chewing Gum

By LabMedica International staff writers
Posted on 07 Oct 2025

Influenza is one of the most dangerous infectious diseases worldwide, claiming around half a million lives each year. More...

What makes it particularly insidious is that flu viruses are contagious even before the first symptoms appear. Yet, diagnostic options are often expensive, complicated to use, and unavailable in many poorer regions. Now, a new, very simple self-test in the form of chewing gum or a lollipop could detect infection within minutes by producing a recognizable taste when an active virus is present.

This rapid test, developed by researchers at the University of Würzburg (Würzburg, Germany), is based on a diagnostic principle that combines a sensor molecule (thymol, a natural flavor carrier) with a virus-specific recognition component so that active influenza viruses trigger release of the flavor in saliva. The method is flexible: flavor carrier and recognition component can be swapped (sweet, bitter, or salty flavors and alternative pathogen-specific building blocks), and the group envisions delivery formats such as chewing gum or lollipops that require no laboratory, electricity, or medical personnel.

In an experimental study, clinical samples were collected and documented by hospital teams while investigations on influenza virus particles were carried out in partner labs to validate the sensor concept. The proof-of-concept work, published in ACS Central Science, shows that contact between active influenza viruses and the neuraminidase-specific sensor releases the flavoring molecule, producing a clearly recognizable taste in infected mouths but not in uninfected controls. as.

The researchers are now working on incorporating the sensors into chewing gum or lollipops and adapting the system for mass production, a process they estimate will take about four years. They believe such low-threshold diagnostics would be particularly suitable for critical locations such as schools, nurseries, and retirement homes, and could be crucial in poorer countries for outbreak control. In the longer term, they envisage voluntary reporting via a smartphone app to map spread in real time and the use of artificial intelligence (AI) to predict where epidemics or pandemics might develop.

“Instead of relying on expensive and complicated testing procedures, we use the natural human sensory system – taste – as a tool for the early detection of infections,” said Professor Lorenz Meinel, who led the study. “This strategy opens up new possibilities for the early detection and control of influenza worldwide.”

Related Links:
University of Würzburg


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
New
Automated Immunoassay Analyzer
SuperFlex™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Molecular Diagnostics

view channel
Image: The Avantect Pancreatic Cancer Test combines epigenomic, genomic, and glycan biomarkers with machine learning to detect pancreatic cancer-associated signals in blood (Photo courtesy of ClearNote Health)

Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic Cancer

Pancreatic ductal adenocarcinoma remains difficult to detect early and monitor during treatment, particularly in patients with homologous recombination defects. Clinicians also have limited noninvasive... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.